MESO Nasdaq update, page-5745

RE: Post #: 75254781

Hi @Timm-Dah,

re your comment: " (Trump v Harris) ...That result can affect FDA decisions, particularly stem-cell ones with Republican parties not tending to like new-found science that has companies "playing God"...":

I like to see threads stay close to their central theme, but political opinions seem to find their way into everything these days. Polarisation is a dangerous fact of life, it seems. Your suggestion about the position of 'Republican parties' is not a view that I share, so I thought I'd add some (potentially) relevant facts to the discussion:

- Donald Trump's tenure as the 45th president of the United States began with his inauguration on January 20, 2017, and ended on January 20, 2021. Ref: https://en.wikipedia.org/wiki/Presidency_of_Donald_Trump

- During the 115th Congress (2017-2019) the USA House of Representatives was majority-controlled by Republicans.
Ref: https://en.wikipedia.org/wiki/Party_divisions_of_United_States_Congresses.

- Scott Gottlieb, MD was appointed by then-President D. Trump as FDA Commissioner in May 2017. Gottlieb's views apparently continued to enjoy President Trump's interest, even after eventually being replaced by the Biden administration, e.g. https://www.statnews.com/2021/09/21/scott-gottlieb-trump-shadow-commissioner/

- The August 28, 2017 speech by Gottlieb linked here focusses on 'stem' cell research & the role of the FDA. I encourage all MSB holders to read the statement in full, especially the comments on Regenerative Medicines Advanced Therapy (RMAT) and cellular therapies:


...and, in particular:



So, IMO this is one of the most definitive & compelling statements of forward planning on the FDA's proper approach to cellular therapies. It was spoken & publicised with the full authority of the Republican-nominee appointment FDA Commissioner, under a Republican Congress, under a Republican President.

One might speculate as to what has caused delays over the years since then, the role of COVID-19 etc.

But, as a present factual matter that I'd suggest is relevant to the future of the FDA's GVHD therapies under a Republican administration, there's this:


...and this in the last 7 days:

https://www.c-span.org/video/?c5085753/house-majority-leader-steve-scalise-update-cancer-treatment

Food for thought, I'd suggest.

Cheers all.
GLTA(LT)H